A recent study published in the *British Journal of Ophthalmology* has linked weight loss drugs, particularly Wegovy and Ozempic, to a rare condition known as ischemic optic neuropathy, commonly referred to as 'eye stroke.' This condition can result in sudden and potentially permanent vision loss. Researchers found that Wegovy was associated with a risk nearly five times greater than Ozempic. Dr. Rohit Shetty, a cornea specialist, emphasized the importance of seeking immediate medical attention for symptoms like sudden blurred vision or visual field defects. While the benefits of these medications in treating obesity and diabetes are significant, the findings raise critical safety concerns as their usage continues to grow. Individuals with pre-existing conditions such as hypertension or diabetes are particularly at risk. Previous studies have also reported severe vision issues among patients using these drugs. Experts recommend comprehensive eye exams before starting any weight-loss medication to catch potential issues early.